Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Clinical trial NCT06304350 · RECRUITING
Trial details
- NCT number
- NCT06304350
- Sponsor
- Tongji University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-17
- Primary completion
- 2026-02-25
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.